Association between interaction and ratio of ω-3 and ω-6 polyunsaturated fatty acid and the metabolic syndrome in adults

Nutrition

Volumn 28, Issue 9, 2012, Pages 856-863

  Mirmiran, Parvin ^a   Hosseinpour Niazi, Somayeh ^b   Naderi, Zahra ^b   Bahadoran, Zahra ^b   Sadeghi, Mahbobeh ^b   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Linolenic acid; 6 3 Ratio; Docosahexaenoic acid; Eicosapentaenoic acid; Metabolic syndrome; Polyunsaturated fatty acid

Indexed keywords

ARACHIDIC ACID; DOCOSAHEXAENOIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NUTRITIONAL ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-LINOLENIC ACID; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIET; DIET SURVEYS; DIETARY FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; YOUNG ADULT;

EID: 84864516631     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.11.031     Document Type: Article

References (54)

1. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
2. Zarich S.W. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations. Minerva Cardioangiol 2006, 54:195-214.
3. Simopoulos A.P. Essential fatty acids in health and chronic diseases. Forum Nutr 2003, 56:67-70.
4. Carpentier Y.A., Portois L., Malaisse W.J. N-3 fatty acids and the metabolic syndrome. Am J Clin Nutr 2006, 83. 1499S-504.
5. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, 71(1 suppl). 343S-8.
6. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008, 233:674-688.
7. Warensjö E., Sundström J., Lind L., Vessby B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 2006, 84:442-448.
8. Freire R.D., Cardoso M.A., Gimeno S.G., Ferreira S.R. Japanese-Brazilian Diabetes Study Group. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care 2005, 28:1779-1785.
9. Mozaffarian D., Ascherio A., Hu F.B., Stampfer M.J., Willett W.C., Siscovick D.S., et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005, 111:157-164.
10. Brady L.M., Lovegrove S.S., Lesauvage S.V., Gower B.A., Minihane A.M., Williams C.M., et al. Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. Am J Clin Nutr 2004, 79:983-991.
11. Lovegrove J.A., Lovegrove S.S., Lesauvage S.V., Brady L.M., Saini N., Minihane A.M., et al. Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians. Am J Clin Nutr 2004, 79:974-982.
12. Ghafoorunissa Requirements of dietary fats to meet nutritional needs & prevent the risk of atherosclerosis-an Indian perspective. Indian J Med Res 1998, 108:191-202.
13. Minihane A.M., Brady L.M., Lovegrove S.S., Lesauvage S.V., Williams C.M., Lovegrove J.A. Lack of effect of dietary n-6:n-3 PUFA ratio on plasma lipids and markers of insulin responses in Indian Asians living in the UK. Eur J Nutr 2005, 44:26-32.
14. Griffin M.D., Sanders T.A., Davies I.G., Morgan L.M., Millward D.J., Lewis F., et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006, 84:1290-1298.
15. Azizi F., Rahmani M., Emami H., Mirmiran P., Hajipour R., Madjid M., et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 2002, 47:408-426.
16. Azizi F., Ghanbarian A., Momenan A.A., Hadaegh F., Mirmiran P., Hedayati M., et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10:5.
17. Mirmiran P., Hosseini-Esfahani F., Mehrabi Y., Hedayati M., Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran Lipid and Glucose Study. Public Health Nutr 2009, 13:645-662.
18. Ghafarpour M., Houshiar-Rad A., Kianfar H. The manual for household measures, cooking yields factors and edible portion of food 1999, Keshavarzi Press, Tehran.
19. Azar M., Sarkisian E. Food composition table of Iran 1980, National Nutrition and Food Research Institute, Shadid Beheshti University, Tehran.
20. Krishka A.M., Knowler W.C., Laprte R.E., Drash A.L., Wing R.R., Blair S.N., et al. Development of questionnaire to examine relationship of physical activity and diabetes in Prima Indians. Diabetes Care 1999, 13:401-411.
21. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32(9 suppl):S498-S504.
22. Azizi F., Hadaegh F., Khalili D., Esteghamati A., Hosseinpanah F., Delavari A., et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med 2010, 13:426-428.
23. Storlien L.H., Pan D.A., Kriketos A.D., O'Connor J., Caterson I.D., Cooney G.J., et al. Skeletal muscle membrane lipids and insulin resistance. Lipids 1996, 31:S261-S265.
24. Smith B.K., Holloway G.P., Reza-Lopez S., Jeram S.M., Kang J.X., Ma D.W. A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance. Appl Physiol Nutr Metab 2010, 35:699-706.
25. Guebre-Egziabher F., Rabasa-Lhoret R., Bonnet F., Bastard J.P., Desage M., Skilton M.R., et al. Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur J Clin Nutr 2008, 62:1287-1293.
26. Risérus U. Fatty acids and insulin sensitivity. Curr Opin Clin Nutr Metab Care 2008, 11:100-105.
27. Willett W.C. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J Cardiovasc Med (Hagerstown) 2007, 8(suppl 1):S42-S45.
28. Zhang L., Geng Y., Xiao N., Yin M., Mao L., Ren G., et al. High dietary n-6/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1. J Atheroscler Thromb 2009, 16:463-471.
29. Hu F.B., Stampfer M.J., Manson J.E., Rimm E.B., Wolk A., Colditz G.A., et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999, 69:890-897.
30. Petersson H., Basu S., Cederholm T., Risérus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle aged men. Br J Nutr 2008, 99:1186-1189.
31. Petersson H., Lind L., Hulthe J., Elmgren A., Cederholm T., Risérus U. Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 2009, 203:298-303.
32. Sacks F.M., Campos H. Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms. J Clin Endocrinol Metab 2006, 91:398-400.
33. De Caterina R., Liao J.K., Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000, 71. 213S-23.
34. Lee J.S., Pinnamaneni S.K., Eo S.J., Cho I.H., Pyo J.H., Kim C.K., et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 2006, 100:1467-1474.
35. Summers L.K., Fielding B.A., Bradshaw H.A., Ilic V., Beysen C., Clark M.L., et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002, 45:369-377.
36. Lichtenstein A.H., Moustaid-Moussa N. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 2010, 140:1915-1922.
37. Behme M.T. Dietary fish oil enhances insulin sensitivity in miniature pigs. J Nutr 1996, 126:1549-1553.
38. Noel S.E., Newby P.K., Ordovas J.M., Tucker K.L. Adherence to an (n-3) fatty acid/fish intake pattern is inversely associated with metabolic syndrome among Puerto Rican adults in the Greater Boston area. J Nutr 2010, 140:1846-1854.
39. Ramel A., Martinéz A., Kiely M., Morais G., Bandarra N.M., Thorsdottir I. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 2008, 51:1261-1268.
40. Fasching P., Ratheiser K., Waldhäusl W., Rohac M., Osterrode W., Nowotny P., et al. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 1991, 40:583-589.
41. Popp-Snijders C., Schouten J.A., Heine R.J., van der Meer J., van der Veen E.A. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 1987, 4:141-147.
42. Giacco R., Cuomo V., Vessby B., Uusitupa M., Hermansen K., Meyer B.J., et al. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?. Nutr Metab Cardiovasc Dis 2007, 17:572-580.
43. Baik I., Abbott R.D., Curb J.D., Shin C. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 2010, 110:1018-1026.
44. Brostow D.P., Odegaard A.O., Koh W.P., Duval S., Gross M.D., Yuan J.M., et al. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 2011, 94:520-526.
45. Hu F.B., Bronner L., Willett W.C., Stampfer M.J., Rexrode K.M., Albert C.M., et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287:1815-1821.
46. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Willett W.C., Rimm E.B. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108:155-160.
47. Verduci E., Radaelli G., Salvioni M., Riva E., Giovannini M. Plasma long-chain fatty acids profile and metabolic outcomes in normolipidaemic obese children after one-year nutritional intervention. Acta Paediatr 2011, 100:585-589.
48. Scaglioni S., Verduci E., Salvioni M., Bruzzese M.G., Radaelli G., Zetterström R., et al. Plasma long-chain fatty acids and the degree of obesity in Italian children. Acta Paediatr 2006, 95:964-969.
49. Ghosh A., Bose K. Das Chaudhuri AB. Association of food patterns, central obesity measures and metabolic risk factors for coronary heart disease (CHD) in middle aged Bengalee Hindu men, Calcutta, India. Asia Pac J Clin Nutr 2003, 12:166-171.
50. Micallef M., Munro I., Phang M., Garg M. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 2009, 102:1370-1374.
51. Grønn M., Gørbitz C., Christensen E., Levorsen A., Ose L., Hagve T.A., et al. Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study. Scand J Clin Lab Invest 1991, 51:255-263.
52. Friedberg C.E., Janssen M.J., Heine R.J., Grobbee D.E. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998, 21:494-500.
53. Barazzoni R., Zanetti M., Ferreira C., Vinci P., Pirulli A., Mucci M., et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab 2007, 92:3935-3940.
54. Chen C.Y., Asakawa A., Fujimiya M., Lee S.D., Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 2009, 61:430-481.